11ß hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.
Br J Cancer
; 123(1): 61-71, 2020 07.
Article
in En
| MEDLINE
| ID: mdl-32336752
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Carcinoma, Non-Small-Cell Lung
/
11-beta-Hydroxysteroid Dehydrogenase Type 1
/
Immune Checkpoint Inhibitors
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2020
Document type:
Article
Affiliation country:
Japón
Country of publication:
Reino Unido